Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.32
0.0000
Volume:269.80K
Turnover:355.89K
Market Cap:135.96M
PE:-1.28
High:1.34
Open:1.32
Low:1.31
Close:1.32
52wk High:2.82
52wk Low:0.5632
Shares:103.00M
Float Shares:95.79M
Volume Ratio:0.48
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0338
EPS(LYR):-1.8117
ROE:-409.87%
ROA:-84.23%
PB:31.10
PE(LYR):-0.73

Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jun 03

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

Inovio Pharma Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
Jun 01

Inovio price target lowered to $2.50 from $3 at H.C. Wainwright

TIPRANKS
·
Jun 01

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 29

Inovio to join Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 28

Inovio Pharmaceuticals Inc. Stock Slips 6.7%, Underperforms Peers

Dow Jones
·
May 27

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 23

Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Vera Therapeutics (VERA)

TIPRANKS
·
May 22

Inovio Says China Partner Reported VGX-3100 Phase 3 Trial Met Primary Efficacy Endpoint in Cervical Dysplasia Patients

MT Newswires Live
·
May 22

Inovio Pharmaceuticals Inc. Stock Advances 8.1%, Outperforms Peers

Dow Jones
·
May 22

Inovio partner ApolloBio says VGX-3100 Phase 3 cervical dysplasia trial hits endpoint

Reuters
·
May 22

Positive Topline Results From a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by Apollobio, Inovio's Partner in China

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals Inc - VGX-3100 Phase 3 Trial Meets Primary Endpoint With Favorable Safety Profile

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals Inc - Apollobio to Pursue Regulatory Submission for VGX-3100 in China

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals held annual shareholder meeting, investors elected eight directors

Reuters
·
May 21

Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze

TIPRANKS
·
May 20

Inovio Pharmaceuticals Inc. Stock Slides 6.2%, Underperforms Peers

Dow Jones
·
May 19

Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain

TIPRANKS
·
May 15